OncoSynergy
  • Science
    • Overview
    • Clinical Trials
    • Scientific Advisory Board
    • Pipeline
  • News
  • About
    • Our Mission
    • Our Team
    • Glioblastoma
  • Connect
    • Fundraisers
    • Contact Us
Press enter to begin your search
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy

Company Info

Stamford, CT, 06902 USA
info@oncosynergy.com

Latest News

  • OncoSynergy Launches Phase I Trial for Patients With Recurrent Glioblastoma November 17, 2020
  • OncoSynergy Receives $300K STTR Grant to Develop Novel Oncolytic Virus January 24, 2020
  • FDA Acceptance of IND Application for Phase I Trial of OS2966 in Patients with Recurrent Glioblastoma April 26, 2019

© 2021 OncoSynergy. All Rights Reserved by OncoSynergy, Inc

  • Science
    • Overview
    • Clinical Trials
    • Scientific Advisory Board
    • Pipeline
  • News
  • About
    • Our Mission
    • Our Team
    • Glioblastoma
  • Connect
    • Fundraisers
    • Contact Us